MDxHealth SA (0O8G.L)
| Chiusura precedente | 0,2650 |
| Aperto | 0,2660 |
| Denaro | 0,0000 x 0 |
| Lettera | 0,0000 x 0 |
| Min-Max giorno | 0,2640 - 0,2715 |
| Intervallo di 52 settimane | 0,2640 - 0,2715 |
| Volume | |
| Media Volume | N/D |
| Capitalizzazione | 14,818M |
| Beta (5 anni mensile) | 0,81 |
| Rapporto PE (ttm) | N/D |
| EPS (ttm) | -0,2820 |
| Prossima data utili | N/D |
| Rendimento e dividendo (forward) | N/D (N/D) |
| Data ex dividendo | N/D |
| Stima target 1A | N/D |
- GlobeNewswire
MDxHealth Confirms No Exposure to Silicon Valley Bank or Silvergate Bank
NEWS RELEASE 13 MARCH 2023, 2:00 AM ET / 08:00 CET IRVINE, CA, and HERSTAL, BELGIUM – March 13, 2023 – MDxHealth SA (NASDAQ/Euronext: MDXH), a commercial-stage precision diagnostics company, today confirms that neither MDxHealth SA, nor any of its subsidiaries, have any exposure to Silicon Valley Bank (“SVB”) or Silvergate Bank. About mdxhealth Mdxhealth is a commercial-stage precision diagnostics company that provides actionable molecular information to personalize patient diagnosis and treatme
- GlobeNewswire
MDxHealth Announces Update of Outstanding Shares and Voting Rights
NEWS RELEASE – REGULATED INFORMATIONMARCH 8, 2023, 5:00 pm ET/ 23:00 CET IRVINE, CA, and HERSTAL, BELGIUM – March 8, 2023 – MDxHealth SA (NASDAQ/Euronext: MDXH) (“mdxhealth” or the “Company“), a commercial-stage precision diagnostics company, today announced, in accordance with Article 15 of the Belgian Act of May 2, 2007 on the disclosure of major participations in issuers of which shares are admitted to trading on a regulated market and regarding miscellaneous provisions, that in the context o
- GlobeNewswire
MDxHealth Reports Financial Year 2022 Results and Provides Business Update and Outlook for 2023
NEWS RELEASE - REGULATED INFORMATION8 MARCH 2023, 4:00 PM EST / 22:00 CET Conference call with Q&A today at 4:30 PM EST / 22:30 CET IRVINE, CA, and HERSTAL, BELGIUM – March 8, 2023 – MDxHealth SA (NASDAQ/Euronext Brussels: MDXH) (the "Company" or "mdxhealth"), a commercial-stage precision diagnostics company, today announced its financial results for the fourth quarter and year ended December 31, 2022, and provided a business update and outlook for 2023. Highlights for the fourth quarter and yea
